Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome

NCT ID: NCT03364751

Last Updated: 2023-01-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

179 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-07

Study Completion Date

2019-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to demonstrate in patients with generalized chronic periodontitis that switching from cigarette smoking to using IQOS improves the response to periodontal therapy and the overall oral health status compared to continuing cigarette smoking.

Note: "IQOS" is the Tobacco Heating System (THS) with Marlboro Heatsticks, marketed in Japan under the brand name IQOS

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This was a randomized, controlled, open-label, 2-arm, parallel group ambulatory study with the randomization stratified by daily cigarette consumption over the month (30 days) prior to Visit 1 (10-19 cigarettes/day vs. \> 19 cigarettes/day) and disease severity recorded at Visit 1 (\< 5 mm Pocket Depth \[PD\] vs. ≥ 5 mm PD) based on the most severely diseased tooth, in smokers with generalized chronic periodontitis who are randomized to either switch from cigarette smoking to IQOS use or continuing cigarette smoking.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontal Diseases Chronic Periodontitis Periodontal Pocket Tooth Mobility Gingival Diseases Smoking, Cigarette

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators
The Dentist (Investigator) or Dental Hygienist performing the periodontal assessments will be blinded to the arm allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IQOS arm

\~86 patients, switching from cigarette smoking to IQOS use.

Group Type ACTIVE_COMPARATOR

IQOS

Intervention Type OTHER

Patients will switch from cigarette smoking to ad libitum IQOS use.

Cigarette arm

\~86 patients, continuing cigarette smoking.

Group Type ACTIVE_COMPARATOR

Cigarette

Intervention Type OTHER

Patients will continue to smoke cigarettes ad libitum.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IQOS

Patients will switch from cigarette smoking to ad libitum IQOS use.

Intervention Type OTHER

Cigarette

Patients will continue to smoke cigarettes ad libitum.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient is aged ≥ 30 years old.
2. Patient has smoked on average at least 10 commercially available cigarettes per day for at least 5 years
3. Patient has generalized chronic periodontitis (i.e., more than 30% of diseased teeth with a PD ≥ 4 mm).

Exclusion Criteria

1. Patient has self-reported history of diagnosed systemic diseases (e.g., stroke or acute cardiovascular event within the last 5 years, diabetes, active cancer).
2. Patient received root planing therapy within the 6 months prior to Visit 1.
3. Patient received surgical periodontal therapy within 3 years prior to Visit
4. Patient was treated within the 3 months prior to Visit 1 with systemic antibiotics or was treated with topical antibiotics applied in the mouth.
5. Continuous systemic use of steroidal or non-steroidal anti-inflammatory drugs for more than 20 days during the past 30-day period (except for low dose aspirin, i.e., ≤300 mg).
6. Female patients who are pregnant, breast-feeding, or planning a pregnancy within the course of the study.
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Philip Morris Products S.A.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christelle Haziza, PhD

Role: STUDY_CHAIR

Philip Morris Products S.A.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mase Dental Clinic

Futtsu, Chiba, Japan

Site Status

Tsudanuma Olive Dental Clinic

Narashino, Chiba, Japan

Site Status

Matsunobu Dental Office

Miyako, Fukuoka, Japan

Site Status

Taniguchi Dental Clinic

Sapporo, Hokkaido, Japan

Site Status

Takano Dental Clinic

Chikusei, Ibaraki, Japan

Site Status

Tsukuba Healthcare Dental Clinic

Tsukuba, Ibaraki, Japan

Site Status

AOI Universal Hospital

Kawasaki, Kanagawa, Japan

Site Status

Yoshinaga Dental Office

Uki, Kumamoto, Japan

Site Status

Yoshino Dental Clinic

Kawaguchi, Saitama, Japan

Site Status

Saida Dental Clinic

Tokorozawa, Saitama, Japan

Site Status

Sakai Dental Clinic

Bunkyō, Tokyo, Japan

Site Status

Kudan Dental Clinic

Chiyoda City, Tokyo, Japan

Site Status

Yano Dental Clinic

Chōfu, Tokyo, Japan

Site Status

Nikaido Dental Clinic

Chūō, Tokyo, Japan

Site Status

Mune Dental Clinic

Setagaya City, Tokyo, Japan

Site Status

Kikuchi Dental Clinic

Shinjuku, Tokyo, Japan

Site Status

Miyata Dental Clinic

Toshima City, Tokyo, Japan

Site Status

Kato Dental Clinic

Himi, Toyama, Japan

Site Status

Kimura Dental Clinic

Fukuoka, , Japan

Site Status

Yamashita Dental Office

Fukuoka, , Japan

Site Status

Yasumasu Dental Office

Fukuoka, , Japan

Site Status

Tsukiyama Dental Clinic

Fukuoka, , Japan

Site Status

Yoshida Shigeru Dental Office

Fukuoka, , Japan

Site Status

Yamashita Dental Clinic

Kagoshima, , Japan

Site Status

Heart Dental Clinic

Kagoshima, , Japan

Site Status

Higashi Dental Office

Kumamoto, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

References

Explore related publications, articles, or registry entries linked to this study.

Pouly S, Ng WT, Benzimra M, Soulan A, Blanc N, Zanetti F, Picavet P, Baker G, Haziza C. Effect of Switching to the Tobacco Heating System Versus Continued Cigarette Smoking on Chronic Generalized Periodontitis Treatment Outcome: Protocol for a Randomized Controlled Multicenter Study. JMIR Res Protoc. 2021 Jan 18;10(1):e15350. doi: 10.2196/15350.

Reference Type BACKGROUND
PMID: 33459599 (View on PubMed)

Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study Authors: Pouly, Sandrine; Ng, Wee Teck; Blanc, Nicolas; Hession, Paul; Zanetti, Filippo; Battey, James N. D.; de La Bourdonnaye, Guillaume; Heremans, Annie; Haziza, Christelle Journal Title: Frontiers in dental medicine Publication Date: 7/22/2022 Volume: 3 DOI: 10.3389/fdmed.2022.915079

Reference Type RESULT

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P1-OHS-01-JP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.